DRAP Issues Multiple Alerts on Falsified, Unregistered, and Substandard Medicines
DRAP Recall ALERT: CRACKDOWN AGAINST UNLICENSED / UNAUTHORIZED MANUFACTURERS DRAP Alert No: I/S/12-25-124Action Date: 30 December 2025 Target Audience Regulatory
Pharma Bulletin
DRAP Recall Falsified, Spurious & Substandard Medicines
On December 18, 2025 – DRAP Recall Falsified/Spurious/ unregistered Tramadol tablets & Substandard betahist 16mg & Glitric 2.6mg Tablets DRAP
DRAP Recall Alert-Substandard batches of Ascard 75mg, PREVASMA Sachets and other medicines
DRAP Recall Alert-Substandard batches of Ascard 75mg, PREVASMA Sachets, Neudex injection and Ame-Pin injection Recall Alert No. 119 Class-II Recall
DRAP Recall-KANADEX-N cream’s Substandard Batches
Date: October 24, 2025DRAP Recall Alert No.: II/S/10-25-101 Target Audience: – National Regulatory Field Force– Healthcare Professionals (Physicians, Pharmacists, Nurses)–
DRAP Recalls substandard batches of Ascard, Amloshine, & Lignozin-A and Satamin injections
In the last week of September,2025 Drug regulatory authority of Pakistan has issued many recalls of substandard, misbranded and adulterated
DRAP Rapid Alert – Illegal & Unsafe Sildenafil Tablets (PENAGRA, VEGA, COBRA) Sold in Pakistan
Unregistered Indian-Origin Illegal & Unsafe Sildenafil Tablets (PENAGRA, VEGA, COBRA) Being Sold Illegally Recall Alert | September 12, 2025 DRAP
DRAP RECALL ALERT! MEDICINES OF UNLICENSED / UNAUTHORIZED MANUFACTURERS
DRAP Recall Alert No.: I/S/09-25-59 Date of Action: 10th September 2025 Intended Audience: Regulatory Field Force of DRAP and Provincial
DRAP ALERT- FALSIFIED / SPURIOUS DRUG PRODUCTS IDENTIFIED
DRAP Alert No: I/S/08-25-56Date of Action: 20th August 2025Intended Audience: Regulatory Field Force of DRAP and Provincial Drug Control Departments
DRAP recall More Batches of Famila 28F tablets along with other medicines
DRAP Alert No. II/S/08-25-55Action Date: 18 August 2025Target Audience: DRAP’s National Regulatory Field Force Provincial Drug Control Departments Hospitals, pharmacies,
DRAP Recall alert of Famila-28F Tablets
DRAP RECALLS-BATCHES OF ‘TABLET FAMILA 28F’ DECLARED SUBSTANDARD BY CENTRAL DRUGS LABORATORY KARACHI. Target Audience: DRAP’s national regulatory field force
DRAP recall alert of “AMOXIL Suspension & AMOXIL forte Suspension”
DRAP RECALL ALERT OF “AMOXIL SUSPENSION AND AMOXIL FORTE SUSPENSION” due to complaint of Induction Seal. DRAP Alert No: II/V/08-25-53Date
FDA Seeks Public Opinion on Menopause Hormone Therapy Risks and Benefits
On July 17, 2025, the FDA brought together a panel of experts to discuss the benefits and risks of hormone
DRAP recall Substandard Medicines-27 June-2025
DRAP recall ⚠️Substandard Medicines⚕️-27 June-2025 The Directorate of Drug Control (DDC) Punjab has notify DRAP (drug regulatory authority of Pakistan)
DRAP Recall the Products Containing HYDROXYPROGESTERONE CAPROATE
DRAP RECALL ⚠️The PRODUCTS CONTAINING HYDROXYPROGESTERONE CAPROATE💉 DRAP (Drug regulatory authority of Pakistan has recalled and suspends the registration of
DRAP recall alert-23 June 2025
DRAP Recalls: Substandard Medicine : Famobex Suspension by Cibex (Pvt.) Ltd. The Drug Regulatory Authority of Pakistan (DRAP) has issued
Latest DRAP Recalls – June 2025 Drug Safety Update
DRAP Recall Alert⚠️Recall of Substandard “Tovir 0.5mg Tablet” having Batch No. 55, Manufactured by M/s Adamjee Pharmaceuticals (Pvt.) Ltd, Karachi.
FDA approves tafasitamab-cxix for relapsed or refractory follicular lymphoma (FL)
FDA approves ✔️ Tafasitamab-cxix for relapsed or refractory follicular lymphoma (FL) On June 18, 2025, The FDA has approved tafasitamab-cxix
Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews
Meijer Issues Recall on Frederik’s Dark Chocolate Almonds Due to Presence of Undeclared Cashews GRAND RAPIDS, Mich. – Meijer has issued
DRAP’s action on Medroxyprogesterone acetate associated meningioma risk
DRAP’s Action on Medroxyprogesterone Acetate in Response to Meningioma Concerns and US Lawsuits Amid the ongoing lawsuits in the US
LATEST DRAP RECALL ALERT OF MEDICINES
DRAP RECALL ALERT-JUNE 2025 Drug regulatory authority of Pakistan (DRAP) is responsible for the regulation of drugs and therapeutic drugs